PROTECT in print: A success for biomarker-guided HF therapy TheHeart.Org Washington, DC - Attentive management of patients with chronic systolic heart failure using natriuretic-peptide levels to guide drug-therapy adjustments significantly cut the risk of cardiovascular events in a small, single-center randomized trial [1]. ... Biomarker-guided heart failure treatment significantly reduces complications |
